Stroke as the disease is a leading cause of death and disability in the United States. Despite scientific and technological advances, there has been limited translation into clinical outcome benefits for stroke patients. A cohesive and integrated Stroke Trials Network has been working to develop breakthrough stroke treatments with an emphasis on rapid execution of clinical trials with sufficient sample sizes, robust enrollment, timely completion, and rigorous and uniform infrastructure across sites. This application is in response to the recent NINDS request for Regional Coordinating Stroke Centers (RCC) in the NINDS Stroke Trials Network (PAR-17-276).
|Effective start/end date||8/1/19 → 7/31/21|
- University of Chicago (AWD100391(SUB00000187)//5U24NS107233-03)
- National Institute of Neurological Disorders and Stroke (AWD100391(SUB00000187)//5U24NS107233-03)